11 /100
LOW RISK
Score updated Jul 13, 2026

XMTR — Xometry, Inc. Dilution Risk Tracker

Track XMTR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XMTR — Get alerts when the score changes →

As of July 13, 2026, Xometry, Inc. (XMTR) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. Xometry, Inc. has a market capitalization of $5.01B, 46.12M shares outstanding, 254 institutional holders tracked. Key dilution vectors include approximately 156 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for XMTR.
🔔 Track XMTR — Get forecast alerts →

💹 Market Data

Market Cap$5.01B
Shares Outstanding46.12M
Float45.44M
Cash$223.97M
Debt$15.86M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 6.3% shares (2026Q1 vs prior)
254 institutional holders · 56.40M shares
#1 PRIMECAP MANAGEMENT CO/CA/ 6.50M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 3.96M shares
#3 BlackRock, Inc. 3.50M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.54M
Days to Cover4.2
% of Float7.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for XMTR Shareholders

Xometry, Inc. (XMTR) has a DilutionScore of 11/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for XMTR shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for XMTR in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for XMTR alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track XMTR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XMTR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for XMTR
📊 XMTR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XMTR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.